期刊
FUTURE LIPIDOLOGY
卷 2, 期 4, 页码 403-422出版社
FUTURE MEDICINE LTD
DOI: 10.2217/17460875.2.4.403
关键词
Alzheimer's disease; arachidonic acid; CDP-choline; CNS injury; docosahexaenoic acid; Huntington disease; lipid peroxidation; neurodegenerative diseases; phospholipases; phospholipids; stroke
资金
- NINDS NIH HHS [R01 NS042008-04, R01 NS042008, R01 NS042008-03, R01 NS042008-02, R01 NS042008-01A2] Funding Source: Medline
Lipid metabolism in CNS is of particular interest because of the high concentration of lipids. The importance of lipids in cell signaling and tissue physiology is demonstrated by many CNS disorders and injuries that involve deregulated metabolism. The long-suffering lipid field is gaining reputation and respect, as evidenced through the Center of Biomedical Research Excellence in Lipidomics and Pathobiology (COBRE), Lipid MAPS (Metabolites And Pathways Strategy) Consortium sponsored by NIH, European initiatives for decoding the lipids through genomic approaches, and Genomics Of Lipid-associated Disorder (GOLD) project initiated by the Austrian government. This review attempts to provide an overview of the lipid imbalances associated with neurological disorders (Alzheimer's disease, Parkinson's disease, Niemann-Pick disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, schizophrenia, bipolar disorders and epilepsy) and CNS injury (stroke, traumatic brain injury and spinal cord injury), as well as a few provocative thoughts. Lipidomic analyses along with RNA silencing will provide new insights into the role of lipid intermediates in cell signaling and hopefully open new avenues for prevention or treatment options.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据